MedPath

Double-blind, placebo-controlled study for the effect of rutin-rich processed buckwheat (Manten-kirari) on dyslipidemia and antioxidant

Phase 3
Conditions
dyslipidemia
Registration Number
JPRN-UMIN000015682
Lead Sponsor
Hokkaido Information University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Subjects who are under medication for chronic ailments. (2) Subjects with serious diseases and infections. (3) Subjects with clinical history of gastrointestinal surgery. (4) Subjects with frequent complaints of post-menopausal symptoms. (5) Subjects with Familial hypercholesterolemia. (6)Subjects with unusually high and/or low blood pressure, or with abnormal hematological data. (7) Subjects with serious anemia. (8)Subjects with a history of allergy to medicine and food, especially buckwheat and wheat (9) Subjects routinely on supplementation which would affect lipid metabolism. (10) Subjects routinely on supplementation which would affect blood pressure. (11) Heavy smokers and alcohol addicts, or subjects with irregular lifestyle. (12) Subjects who donate 400ml whole blood within 12 weeks or who donate plasma or platelets within 4 weeks prior to supplementation. (13) Subjects who are pregnant or under lactation, or ones who would be expected to be pregnant during the study. (12) Subjects who participate in other clinical trials within the last one month prior to the current clinical trial. (13) Subjects who are not eligible due to physician's judgment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath